alpha interferon combin zidovudin treatment presymptomat felin leukemia virus-induc immunodefici syndrom therapeut efficaci human recombin alpha interferon ifn-alpha ifn-alpha zidovudin azt azt presymptomat cat felin leukemia viru felv immunodefici syndrom faid infect high level persist antigenemia subcutan inject human recombin ifn-alpha kg peak concentr plasma u/ml postadministr half-lif elimin dosag ifn-alpha cat week signific clinic toxic oral administr azt mg/kg time peak concentr plasma micrograms/ml half-lif elimin treatment felv-faids-infect cat ifn-alpha combin azt signific decreas core antigen week initi therapi azt effect viru antigen high u/kg low u/kg -dosag ifn-alpha cat refractori week begin treatment time ifn-alpha-tr anim antibodi ifn-alpha specif human recombin ifn-alpha dose depend magnitud result studi human recombin ifn-alpha effect viru antigen load cat felv-faid 